对比
Abnormal Circulating Alpha Mannosidase Activity C5872950 vs Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
二者是不同系统的异常结果，而非诊断。前者为循环酶检测结果，后者为视锥通路视网膜电图结果，需专科解读。
Abnormal Circulating Alpha Mannosidase Activity C5872950
Reduced activity of an enzyme that breaks down certain sugars in cells. This can lead to a rare disorder causing intellectual disability, hearing loss, and skeletal abnormalities. Management is supportive.
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
An abnormal eye test response to flickering light, which tests cone cell function. This finding may indicate problems with color vision cells and typically requires specialist eye evaluation.
6 个对比维度
Onset
Abnormal Circulating Alpha Mannosidase Activity C5872950
Variable
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Variable
Onset patterns differ
Severity
Abnormal Circulating Alpha Mannosidase Activity C5872950
moderate
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
moderate
Different severity levels
Chronic
Abnormal Circulating Alpha Mannosidase Activity C5872950
Chronic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
Chronic
Differing course
Communicable
Abnormal Circulating Alpha Mannosidase Activity C5872950
No
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
No
Different transmission
Body System
Abnormal Circulating Alpha Mannosidase Activity C5872950
metabolic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
ophthalmologic
Same/different system
Category
Abnormal Circulating Alpha Mannosidase Activity C5872950
metabolic
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
genetic
Different category
结论
abnormal-circulating-alpha-mannosidase-activity-C5872950 and abnormal-amplitude-of-light-adapted-flicker-electroretinogram-C4072969 differ in etiology
关键鉴别要点
在床旁或检查过程中最能可靠区分两种疾病的发现。
| 特征 | Abnormal Circulating Alpha Mannosidase Activity C5872950 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | 鉴别力 |
|---|---|---|---|
| 主要异常 | 循环α-甘露糖苷酶活性降低或其他异常 | 明适应30 Hz闪烁ERG波幅异常 | High |
| 临床背景 | 可促使评估溶酶体贮积病，但不能确立诊断 | 提示可能存在视锥功能障碍，需眼科对照 | High |
| 相关表现 | 仅在确诊疾病时才可能有发育、听力或骨骼问题 | 可有色觉、中心视力或畏光问题，但并非必需 | Moderate |
何时更支持某种疾病
选择 Abnormal Circulating Alpha Mannosidase Activity C5872950 的情况
不明原因的发育、听力或骨骼表现
酶结果可支持针对性代谢评估
Moderate
家族史提示溶酶体疾病
循环酶检测可纳入专科检查
Moderate
需解释代谢实验室异常
该结果属于生化检测而非视网膜检测
High
选择 Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 的情况
怀疑视锥或色觉功能障碍
明适应闪烁ERG评估视锥通路反应
High
不明原因的中心视力症状
波幅异常需眼科进一步对照
Moderate
需描述视网膜电生理结果
该结果针对眼部，不是代谢酶结果
High
关键检查差异
| 检查 | Abnormal Circulating Alpha Mannosidase Activity C5872950 | Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969 | 解读 |
|---|---|---|---|
| 酶活性测定 | 循环α-甘露糖苷酶活性异常 | 视网膜检测不评估该酶 | 酶异常不是诊断，需实验室和临床确认 |
| 明适应闪烁ERG | 不能界定酶结果 | 闪烁波幅异常 | 提示视锥通路功能障碍，需完整ERG和眼部检查 |
| 确认性评估 | 可包括复查、遗传学和代谢评估 | 可包括眼科检查及相关视网膜检测 | 两项结果需各自的专科路径 |
预后对比
Abnormal Circulating Alpha Mannosidase Activity C5872950
- 转归
- 不能仅凭酶结果确定
- 因素
- 是否确诊、酶背景及器官受累
Abnormal Amplitude Of Light Adapted Flicker Electroretinogram C4072969
- 转归
- 不能仅凭ERG波幅确定
- 因素
- 视锥功能障碍病因、视力及检查中的进展
时间范围: 因病因而异
两项结果都没有统一预后
并发症对比
| 并发症 | 表现 |
|---|---|
| 错误归类 | 把酶结果当作已确诊贮积病 把ERG结果当作特定视网膜诊断 二者都只是结果，诊断需要更多证据 |
| 专科评估延迟 | 可能延误代谢或遗传评估 可能延误眼科评估 影响取决于尚未确定的病因 |
| 相关病损 | 若确诊，可能出现发育、听力或骨骼问题 若确诊视网膜病，可能影响视觉功能 不能仅凭任一结果推断这些结局 |
患者教育要点
- High结果与诊断
异常检测本身不能证明疾病，应询问还需哪些复查。
- High对应专科
酶异常由代谢或遗传专科评估，ERG异常由眼科评估。
- Medium家族意义
某些病因可能遗传，但不能仅凭这些结果判断。